跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VASEREL - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
VASEREL
Approved
STANDARD
VASEREL
Aurochem Laboratories (India) Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8cf8a91c1a50f606
Company
Aurochem Laboratories (India) Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
8cf8a91c1a50f606
Drug Approval Philippines Name
VASEREL
Product Name
VASEREL
Registration Number
DR-XY43321
Brand Name
VASEREL
Generic Name
TRIMETAZIDINE HYDROCHLORIDE
Dosage Form
Modified Release Film-Coated Tablet
Dosage Strength
35mg
Manufacturer
Aurochem Laboratories (India) Pvt. Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
25 April 2024
Expiry Date
15 April 2029
Pharmacologic Category
Fatty Acid Oxidation (pFOX) Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8cf8a91c1a50f606
Type
Standard
Back to Philippines FDA Approvals